Bellevue, Washington, November 18, 2020 - - Novo Integrated Sciences, Inc. (OTC US: NVOS), a provider of multi-dimensional primary healthcare services and products in Canada and the U.S. (the “Company"), announces it has engaged Investor Acquisition Advisors to enhance the investor community’s market awareness of Novo Integrated Sciences through Investor Acquisition Advisors’ expertise and its proprietary investor acquisition equity research and digital marketing platform. Mr. Robert...
NEWSROOM
NVOS
Novo Integrated Sciences Engages Maxim Group LLC to Assist with its Growth Strategy and Goal to Up-list to a National Exchange
Bellevue, Washington, August 11, 2020 - - Novo Integrated Sciences, Inc. (OTCQB: NVOS) ("Novo Integrated Sciences" or "the Company"), a provider of multi-dimensional primary healthcare services and products in Canada and the U.S., today announced that it has engaged Maxim Group LLC as its financial advisor to assist the Company in articulating its growth strategy to the investment community and with its aspiration to Up-list to a national exchange. Novo Integrated Sciences is looking to list...
Novo Integrated Sciences Provides Business Impact of COVID-19 Pandemic
BELLEVUE, Wash., March 20, 2020 -- Novo Integrated Sciences, Inc. (OTCQB: NVOS) (“Novo Integrated Sciences” or “the Company”) announces precautionary measures the Company is taking to protect the health and safety of its employees, partners and patients as well as the business impact related to the COVID-19 pandemic. Because COVID-19 infections have been reported throughout both Canada and the United States, certain national, provincial, state and local governmental authorities have issued...